LIPTRUZET CONTROL CHOLESTROL REPORTED BY FDA

According to Merck and Co. Liptruzet is a tablet which cures the

treatment of high LDL (Low-Density Lipoprotein) i.e; "bad cholesterol" in patients body. Hyperlipidemia is a high concentration of fats in the blood. Liptruzet contains ezetimibe, plus atrovastation.
Merck says Liptruzet has two source cholestrol:

• Atrovastation reduces the production of cholesterol in the liver.
• Ezetimibe initiates the absorption of cholesterol in the digestive system.

Peter H. Jones, M.D; associates professor of medicine, Baylon College of Medicine, says that the patients are unable to lower their LDL cholesterol . Liptruzet result to be shown to decrease the risk of cardiovascular disease, includes stroke and heart beat.

The FDA has waiting for the major result of study that comparing

the ezetimibe plus. The study is not completed till the end of 2014.

Liptruzet is sold in doses of 10 milligram of ezetimibe plus 10,20,40 or 80 milligram of atrovastain and it is taken daily as a pill. It cost $5.50 doses.

However, the German Institute for Quality and Efficiency in Health Care says that there is lower risk of heart attacks for patients who had ezetimibe plus.

Article of Liptruzet tablet.
Ezetimibe plus reduce cholesterol in human beings